Industry
Helical raises $10M to bridge the gap between foundation models and drug discovery decisions
Pharma artificial intelligence startup Helical Ltd. announced today that it has raised 10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into re
Pharma artificial intelligence startup Helical Ltd. announced today that it has raised 10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into reproducible in-silico drug discovery workflows. Founded in 2024, Helical was built around a specific gap its founders identified as biological foundation models have gained traction […] The post Helical raises 10M to bridge the gap between foundation models and drug discovery decisions appeared first on SiliconANGLE.
Related
- OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery
- Refiant raises $5M to refine AI models with ‘nature-inspired’ energy efficiency
- Parasail raises $32M for its pay-per-token inference cloud
- AI training data startup AfterQuery nabs $30M investment
Source: SiliconANGLE | 2026-04-14